title: Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer.
abstract: Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was approved in Europe for the radioiodine ablation of low-risk differentiated thyroid cancer (DTC) during thyroid hormone therapy with L-thyroxine (L-T4). Moreover, in December 2007, the US Federal Drug Administration approved the use of rhTSH for adjuvant treatment with radioiodine in patients with DTC without evidence of metastatic thyroid cancer. Quality of life was found to be better with rhTSH preparation than with L-thyroxine withdrawal, thereby resulting in benefits for society as a whole. Furthermore, rhTSH for radioiodine remnant ablation results in a longer effective radioiodine half-life within remnant thyroid tissue and a lower specific absorbed dose in the blood and exposure of bone marrow to X-rays. More studies are required to establish the amount of radioiodine to be administered especially in high-risk patients.
authors.affiliation: Department of Clinical and Molecular, Endocrinology and Oncology, University of Naples Federico II, Naples, Italy. bebiondi@unina.it
authors.forename: Bernadette
authors.initials: B
authors.lastname: Biondi
authors.forename: Melania
authors.initials: M
authors.lastname: Pulcrano
authors.forename: Loredana
authors.initials: L
authors.lastname: Pagano
authors.forename: Gaetano
authors.initials: G
authors.lastname: Lombardi
references.citation: J Clin Endocrinol Metab. 1997 Jan;82(1):11-4
references.pmid: 8989223
references.citation: J Clin Endocrinol Metab. 2000 Oct;85(10):3640-5
references.pmid: 11061516
references.citation: Thyroid. 2008 Jul;18(7):687-94
references.pmid: 18630995
references.citation: Eur J Endocrinol. 2007 May;156(5):531-8
references.pmid: 17468188
references.citation: Nucl Med Rev Cent East Eur. 2000;3(1):83-8
references.pmid: 14600988
references.citation: Thyroid. 2001 Sep;11(9):865-9
references.pmid: 11575856
references.citation: J Clin Endocrinol Metab. 2006 Mar;91(3):926-32
references.pmid: 16384850
references.citation: J Nucl Med. 2005 Jan;46 Suppl 1:28S-37S
references.pmid: 15653649
references.citation: J Clin Endocrinol Metab. 2004 Aug;89(8):3668-76
references.pmid: 15292285
references.citation: Endocr Relat Cancer. 2005 Mar;12(1):49-64
references.pmid: 15788638
references.citation: J Endocrinol Invest. 1999;22(11 Suppl):30-4
references.pmid: 10727003
references.citation: J Clin Endocrinol Metab. 1998 Dec;83(12):4195-203
references.pmid: 9851751
references.citation: Eur J Endocrinol. 2006 Sep;155(3):405-14
references.pmid: 16914594
references.citation: Thyroid. 2005 Oct;15(10):1147-55
references.pmid: 16279848
references.citation: J Clin Endocrinol Metab. 2006 Mar;91(3):878-84
references.pmid: 16394083
references.citation: J Clin Endocrinol Metab. 2007 Sep;92(9):3542-6
references.pmid: 17609306
references.citation: N Engl J Med. 1997 Sep 25;337(13):888-96
references.pmid: 9302303
references.citation: J Endocrinol Invest. 2002 Jan;25(1):44-52
references.pmid: 11883865
references.citation: Eur J Endocrinol. 2007 Jan;156(1):13-9
references.pmid: 17218721
references.citation: J Clin Endocrinol Metab. 2002 Sep;87(9):4063-8
references.pmid: 12213846
references.citation: J Clin Endocrinol Metab. 2003 Sep;88(9):4110-5
references.pmid: 12970272
references.citation: J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63
references.pmid: 11297567
references.citation: Endocr Pract. 1998 Sep-Oct;4(5):282-6
references.pmid: 15251726
references.citation: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):924; author reply 924-5
references.pmid: 15034676
references.citation: J Nucl Med. 2002 Nov;43(11):1482-8
references.pmid: 12411552
references.citation: Thyroid. 2008 May;18(5):509-16
references.pmid: 18426363
references.citation: J Nucl Med. 2006 Apr;47(4):648-54
references.pmid: 16595499
references.citation: Eur J Endocrinol. 2006 Jun;154(6):787-803
references.pmid: 16728537
references.citation: Thyroid. 2006 Feb;16(2):109-42
references.pmid: 16420177
references.citation: J Nucl Med. 2004 Sep;45(9):1549-54
references.pmid: 15347723
references.citation: Am J Roentgenol Radium Ther Nucl Med. 1962 Jan;87:171-82
references.pmid: 13867399